After completing a PhD from University of Strathclyde (UK) in 2005, Dr Lim spent 4 years post-doc research at The Hatter Cardiovascular Institute (University College London, UK) focused on cardioprotection research, in particular the role of the mitochondria permeability transition pore and the translational value of ischemic conditioning. In June 2010, he joined the O’Brien Institute (Melbourne) and was appointed as the leader of the Cardiac Regeneration team in 2012. His group focuses on combining stem cell technology and tissue engineering approach to repair and regenerate damaged heart
Tissue Engineering International & Regenerative Medicine Society.
Member 2012 -
High Blood Pressure Research Council of Australia.
Member 2011 -
International Society of Heart Research.
Member 2005 -
2014: The CASS Foundation. (Lim). Cardiac repair and regeneration with novel human cardiac resident stem cells. AUD$50,000.
2014: St Vincent’s Hospital Research Endowment Fund. (Lim, Mitchell, Liu, Newcomb). Constructing a vascularized human heart muscle graft using a 3D collagen scaffold. AUD$17,500.
2013: St Vincent’s Hospital Research Endowment Fund. (Lim, Dusting, Newcomb). Human resident cardiac stem cells for cardiac tissue engineering. AUD$15,000.
2013-14: Friedreich Ataxia Research Association. (Pébay, Lim, Trounce, Needham). Differentiating Friedreich ataxia-induced pluripotent stem cells for disease modelling. AUD$257,400.
2013-14: Australia National Heart Foundation (Dusting, Peshavariya, Lim). Boosting oxidant signalling in endothelial progenitor cells to improve cardiac repair after infarction. AUD $130,000; G12M6726
2012-14: Australia National Health and Medical Research Council project grant (Dusting, Dilley, Pébay, Lim, Shepherd). Upscaling cardiac tissue engineering: Differentiation of iPS cells, enrichment and bionic approaches. AUD $685,710; 1024817
2012-14: UK Medical Research Council project grant (Hausenloy, Lim, Yellon). DJ-1 as a novel target for cardioprotection. £372,796; MR/J003530/1
2012-13: Australia National Heart Foundation (Dusting, Lim, Peshavariya). Cardioprotection in ischaemic heart failure by prostacyclin and oxidant signaling. AUD $130,000; G11M5836
Education and training
University of Strathclyde 2005
University of Strathclyde 2002
Awards and honors
Young Investigator Award, High Blood Pressure Research Council of Australia,